ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2198

Interstitial Lung Disease in Primary Sjogren’s Syndrome: Any Association with IgG4 Related Sclerosing Disease?

Adlene Jebakumar1, Carlotta Nannini2, Eunhee S. Yi3, Hiroshi Sekiguchi4, Jay H. Ryu5, Cynthia S. Crowson6 and Eric L. Matteson1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Rheumatology Unit, Prato Hospital, Prato, Italy, 3Anatomic Pathology, Mayo Clinic, Rochester, MN, 4Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 5Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 6Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and lung

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Clinical

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Various forms of interstitial lung disease (ILD) are associated with primary Sjögren’s syndrome.  IgG4-related sclerosing disease (ISD) is a recently described systemic fibroinflammatory disease associated with dense lymphoplasmacytic infiltrates rich in IgG4-positive plasma cells. Sicca symptoms and ILD are two of the known manifestations of ISD, and are also characteristic of Sjögren’s syndrome. We aimed to describe the lung histopathology in a series of patients with Sjögren’s syndrome who underwent open lung biopsy for evaluation of ILD, and to evaluate the occurrence of IgG4 in the lung parenchyma from a subset of these patients.

Methods:

The archived pathology specimens of 15 patients with primary Sjögren’s syndrome related ILD who underwent lung biopsies between 1998 and 2010 were reviewed, and evaluated for the presence of IG4 by immunohistochemical staining. Diagnosis was based on 2002 American European Consensus Group criteria for primary Sjogren’s syndrome. Patient demographic data and findings from high resolution computed tomography (HRCT) findings of the lungs of these patients were recorded.   

Results:

Among the 15 identified patients, 11 (73%) were female; mean age was 58 years. All of these patients had dry eyes and dry mouth symptoms. Anti-nuclear antibodies were present in 11 (85%) of 13 tested patients. Of 12 patients tested, 12 (100%) had anti- SSA antibodies and 9 (75%) had anti-SSB antibodies. Six (55%) of 11 tested patients were rheumatoid factor positive, and  hypergammaglobulinemia was noted in 9 (75%) of 12 tested patients. Six (40%) patients had positive smoking history. Lung histopathology revealed usual interstitial pneumonia (UIP) in 6 patients; 3 patients had non-specific interstitial pneumonia (NSIP). The other patients had bronchiolitis (n=1), cryptogenic organizing pneumonia (n=1), desquamative interstitial pneumonia (n=1), follicular bronchiolitis with amyloid (n=1), obstructive pneumonitis (n=1), and lymphocytic interstitial pneumonia (n=1). Immunohistochemical staining of these lung biopsy specimens for IgG4 were negative for 7 (100%) of 7 patients. HRCT was performed in 12 of 15 patients. Linear or reticular opacities were noted in 9 patients, ground glass or non-solid opacities in 8 patients, and bronchiectasis in 8 patients. Other common HRCT findings were lymphadenopathy (n=3) honey-combing (n=3), multifocal cysts (n=3) and solid nodules (n=3).

Conclusion:

The most common form of ILD in these patients with Sjögren’s syndrome undergoing lung biopsy is UIP, and the majority had linear and/or ground opacities on HRCT. While there are reports that dacroadenitis and sialoadenitis is associated with IgG4 deposition, we found no evidence of IgG4 in the lung tissue of patients with primary Sjögren’s syndrome suffering from ILD.


Disclosure:

A. Jebakumar,
None;

C. Nannini,
None;

E. S. Yi,
None;

H. Sekiguchi,
None;

J. H. Ryu,
None;

C. S. Crowson,
None;

E. L. Matteson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interstitial-lung-disease-in-primary-sjogrens-syndrome-any-association-with-igg4-related-sclerosing-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology